Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer

Endocrine therapy has historically formed the basis of treatment of metastatic hormone receptor-positive breast cancer. The development of endocrine resistance has led to the development of newer endocrine drug combinations. Use of the CDK4/6 inhibitors has significantly improved progression-free su...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Souza, Anishka, Spicer, Darcy, Lu, Janice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996460/
https://www.ncbi.nlm.nih.gov/pubmed/29891002
http://dx.doi.org/10.1186/s13045-018-0620-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996460/
https://www.ncbi.nlm.nih.gov/pubmed/29891002
http://dx.doi.org/10.1186/s13045-018-0620-6

Ejemplares similares